Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Losartan on Retinal Endothelial Function
NCT00152633Phase 3Withdrawn
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- Sep 2005
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of losartan in essential hypertension, sponsored by FAU Erlangen-Nürnberg Medical Faculty. Planned start Sep 2005; status: withdrawn.
02
Drugs
losartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00152633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152633.